News & Press

Topic: News & Press

MCC Imaging Process Metrics Toolkit v3.0 Now Available

Thursday, May 14, 2020

The MCC Imaging Process Metrics Toolkit v3.0 is now available for MCC member organizations to download from the portal. Thank you to all who provided input and feedback as we carried out this extensive update. The updated metric toolkit includes the following:

  • Updated Metric Definitions
    • Portfolio / Study / Site level metrics
    • Basic / Advanced metric designations
    • Potential Key Risk Indicators
  • New toolkit overview, implementation guide and introductory webinar (13 mins).
  • Updated process map
  • Additional components to assist with your implementation and use of the metrics:
    • Four metric selection tools which help you select the right metrics for your situation and to list the associated data elements needed
    • A metrics reporting planning worksheet to help plan the reporting of the metrics you select

Please visit the MCC Imaging Process Metrics Work Group page for additional information.

Not a member? Contact Terry Holland, MCC Membership Director, to discuss membership options.

New Paper! Measure the Right Things at the Right Time Series

Monday, May 4, 2020

MCC released the second paper in a new Measure the Right Things at the Right Time series. The paper Design Key Risk Indicators and Key Performance Indicators that Provide Timely Insights During Study Conduct outlines an approach to and rationale for the best way to normalize metrics used as leading indicators to provide early signals of risk, such as with Key Risk Indicators, as part of Risk-Based Quality Management in implementation of ICH E6 (R2). How you define your measurements can allow you to see trends and outliers earlier as well as reduce the number of false positives!  View the paper

The first paper in the series Using A Metric Maturity Model to Optimize Performance Measurement describes a 5-stage metric maturity model that align metrics with process maturity stages. Learn how your organization can realign your metric program to focus on measuring meaningful, high value metrics.  View the paper

For a complete listing of free downloadable MCC White Papers click here.

New Forum on Navigating Clinical Trial Operational Challenges Amid COVID-19 Crisis

Friday, April 3, 2020

Metrics Champion Consortium Unveils New Forum to Foster Dialogue on Navigating Clinical Trial Operational Challenges Amid COVID-19 Crisis

Virtual Roundtable Brings Together Industry Stakeholders for Weekly Discussions on How to Measure Risk and Study Performance as Coronavirus Pandemic Evolves

Falls Church, VA – April 3, 2020 – Metrics Champion Consortium (MCC), an industry organization dedicated to improving clinical trials via the development of standardized performance metrics, today announced the launch of a new forum designed to spur discourse on the impact of the coronavirus outbreak on clinical trials and how to tackle operational challenges associated with the ever-evolving pandemic. The weekly, virtual series – the MCC COVID-19 Community of Practice – connects MCC members, representing more than 80 organizations across the global life sciences ecosystem, and provides them with opportunities to share knowledge and collectively think about how to proactively address common industry concerns around risks to trial integrity and benchmarking study performance amid the COVID-19 crisis.

Founded in 2006, MCC is part of WCG’s Study Planning and Site Optimization Division. From biopharmaceutical and medical device trial sponsors to clinical research organizations (CROs), research sites and technology service providers, member organizations utilize MCC’s network to collaborate through working groups focused on addressing shared challenges and opportunities. In light of the COVID-19 pandemic and recent guidance from regulatory bodies on conducting clinical trials, MCC is leveraging its platform to bring together a diverse, global network of clinical research stakeholders to discuss how they are coping with disruptions to study operations as a result of quarantines, site closures, travel limitations, interruptions in the supply chain for the investigational product and infection of site personnel and trial participants, among other ongoing developments. A document summarizing the topics discussed as well as links to relevant consortium resources and regulatory guidance documents are posted in the consortium’s COVID-19 knowledge portal.

“The fallout from the spread of COVID-19 infections will continue to have major implications for clinical trial operations, and we’re committed to doing our part to support our community in navigating through unchartered territory,” said Linda Sullivan, executive director of MCC. “In bringing together MCC members for timely discussions and to regularly compare notes, our goal is to create a forum that drives the knowledge sharing and collaborative thinking that will help to meaningfully address common challenges and offer practical, actionable solutions.”

Donald A. Deieso, PhD, Executive Chairman and CEO of WCG, added: “Collaboration across the clinical trial ecosystem and healthcare more broadly has never been more critical. With the coronavirus pandemic growing rapidly as each day passes, we know that we are all in this together and must find our way through a devastating global health crisis by collaborating and supporting each other. Leveraging its unmatched benchmarking capabilities and insights, MCC is making it possible for the industry to think through needed new metrics and their implications, while working together to determine how to consistently measure performance in an evolving clinical trial landscape.”

Weekly COVID-19 Community of Practice discussions will explore top-of-mind questions on virtual patient visits, risk management and control, centralized monitoring, protocol deviations and amendments, and informed consent form amendments, as well as other topics suggested by members. MCC resources, including a web-based knowledge portal and LinkedIn Group, will also be available to members so that they can share challenges, questions and learnings in real time.

To learn more about MCC membership, please contact Teresa Holland, Membership Director at or 1-317-622-0266.

About Metrics Champion Consortium
MCC is the leading industry consortium that brings clinical research stakeholders together, including sponsors, CROs, partners and investigational sites, to collaboratively develop standardized performance metrics and associated tools that help organizations oversee, manage and optimize clinical trial execution.  For more information, please visit

About WCG
WCG is the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research. Comprised of two divisions – the industry’s first central IRB – WIRB-Copernicus IRB, and first clinical services organization (CSO) – WCG enables biopharmaceutical companies, CROs, and institutions to accelerate the delivery of new treatments and therapies to patients, while maintaining the highest standards of human subject protection. For more information, please visit  or follow us on Twitter @WCGClinical or LinkedIn.

Media Contacts:
MCC: Linda B. Sullivan

WCG: Amy Hutnik

Help Prioritize Topics for the Small Sponsor Community of Practice Group

Monday, August 5, 2019

The MCC Small Sponsor Community of Practice Group has been established in response to feedback about the unique needs of smaller-sponsor members. The purpose of the new group is to provide members with the opportunity to:

  • Share ideas and practical approaches that work in small sponsor settings
  • Get up-to-date news about MCC Performance Metric Sets and Tools
  • Provide feedback about how MCC can support small sponsors

The MCC has designed a survey to gather input from small sponsors about how they would like to use the Small Sponsor Community of Practice Group and the topics they would like to explore. Survey respondents will receive a summary recap of results. Responses will be kept confidential.

The survey is designed for sponsors, CROs, vendors, and consultants but not for investigative sites. MCC gathers input from sites via other methods.

Learn more about the MCC Small Sponsor Community of Practice Group.

Not a member? Contact Terry Holland, MCC Membership Director, to discuss membership options.

Accenture Introduces New Analytics Capabilities in the Accenture Life Sciences Cloud for R&D: Collaborates with the Metrics Champion Consortium to develop the Clinical Operations Insights Platform for Improved Visibility into Clinical Trial Performance

Monday, June 26, 2017


NEW YORK; June 26, 2017 – Accenture (NYSE: ACN) has developed and introduced a new analytics platform to provide real-time insights on the status and performance of clinical trials for the life sciences industry. The platform, known as the Clinical Operations Insights Platform (COIP), is a module of the Accenture Life Sciences Cloud for R&D, an industry platform for running clinical trials that deliver better patient outcomes.

Accenture has joined forces with the Metrics Champion Consortium (MCC) in the development of COIP, using MCC’s industry clinical trial metrics to measure a company’s clinical trial performance. MCC is an open, collaborative organization devoted to the development of standardized metrics to improve clinical trials.

Accenture’s COIP is designed to help life sciences companies leverage descriptive and predictive analytics using operational data to gain real-time insights about the status and performance of a clinical trial. Accenture’s experience has shown that the COIP can help life sciences companies increase the operational efficiency of clinical trials by as much as 30 percent. The platform gives life sciences clinical operations managers greater flexibility to manage clinical trial programs from anywhere, anytime, by consolidating into a single analytics platform internal and external data sources across clinical trial management systems, electronic data capture systems and clinical research organization partners.

“We are excited about our collaboration with MCC and the addition of their clinical operations performance metrics into our Clinical Operations Insights Platform module”, said Kevin Julian, who leads Accenture’s Life Sciences practice in North America “Together we are integrating technology with metrics standards, making it easier for our clients to understand the health of their study portfolio, manage their business more effectively and bring their treatments to patients.”

MCC has also joined the Accenture Life Sciences Cloud Coalition, which includes Eli Lilly, GSK, Merck, Pfizer, and other prominent pharmaceutical companies. As a member of the coalition, MCC will provide input on the use of standardized performance metrics in the Accenture Life Sciences Cloud for R&D. The aim of the Accenture Life Sciences Cloud Coalition is to enable the R&D function, speed up the drug development process while improving quality and cost for the industry.

“We are pleased to build MCC’s standardized metrics into the Accenture Life Sciences Cloud for R&D Clinical Operations Insights Platform and to welcome Accenture as a member of our consortium”, said Linda Sullivan, co-founder, and president of MCC. “Our members are looking for innovative ways to implement and effectively utilize the standardized metric sets and tools developed in our collaborative working groups – having access to MCC standardized performance metrics in the Accenture Life Sciences Cloud for R&D platform is a win-win for current and future users.”

About Accenture

Accenture is a leading global professional services company, providing a broad range of services and solutions in strategy, consulting, digital, technology and operations. Combining unmatched experience and specialized skills across more than 40 industries and all business functions – underpinned by the world’s largest delivery network – Accenture works at the intersection of business and technology to help clients improve their performance and create sustainable value for their stakeholders. With more than 411,000 people serving clients in more than 120 countries, Accenture drives innovation to improve the way the world works and lives. Visit us at

About Metrics Champion Consortium

MCC is a trusted partner in the clinical trials industry to identify what to measure and assess the critical components of what is changing and how the industry is responding to address the changes to make improvements. We continually bring you new insights into the leading trends within the industry. For more information, please visit


Teresa Holland
Metrics Champion Consortium
+ 1 317 622 0266 ext. 108

Cam Granstra
+1 312 693 5992

MCC MetricInsights Newsletter Launch

Friday, June 16, 2017

The MCC recently released a monthly Newsletter. The MetricInsights Newsletter provides professionals with updates on MCC events and key initiatives. It’s all the important news for the month in one place. Sections include Important News, Featured Workgroup, Upcoming Meetings, and More! We are always adding and changing sections so every issue has something new! Read past issues and learn how to subscribe here .

Help Industry Develop Standard Metrics for Site Payments-MCC Site Payments Process Industry Survey

Thursday, April 27, 2017

As an industry, we have a challenge with site payments. Site payment delays have been cited as one of the key concerns by investigators. Data from the Society for Clinical Research Sites (SCRS) says that 66% of sites report having less than three months’ operating cash on hand, and lengthy delays in payment result in high turnover rates among clinical investigators1. The Clinical Trials Transformation Initiative (CTTI) shows as many as 40% of sites drop out of FDA-regulated clinical trials due to lengthy delays in payments2. By standardizing metrics in this important area, the industry will be better able to baseline, compare, manage and improve performance and ultimately increase the available pool of sites for clinical trials.

The Metrics Champion Consortium is conducting this survey as a baseline exercise before developing metrics. We invite industry Sponsor, CRO and Clinical Trial Site Payment Vendors to participate in this 11 question survey. All responses will remain confidential to the MCC – only de-identified data will be shared in the executive summary and final report. Professionals who complete the survey and include their email address will receive an executive summary.


1SCRS White Paper on Site Payments[]

2CTTI Article[]

MCC Article Urges Industry to Standardize Data Entry Metric Definition and Use Performance Data to Improve Data Entry Compliance

Wednesday, April 26, 2017

Linda Sullivan, MCC President, and Keith Dorricott, MCC Ambassador – discussed the results of the 2016 MCC Site Data Entry Practices Survey in their article “Importance of Data Entry Timeliness” published by Applied Clinical Trials. The article reveals that organizations consider timely data entry to be very important but face challenges with measuring and monitoring the data input process. A newly released MCC Industry Practices Insight Report, “Clinical Trial Site Data Entry Study: An examination of how organizations measure site data entry cycle times, performance expectations compared to actual results and site management strategies” provides industry’s perspective on the cycle time from subject visit to data entry by investigative sites, and how organizations use the performance data to improve data entry compliance.

About the Survey

MCC conducted the 28 question, web-based survey between June – August 2016. There were 35 respondents primarily from sponsors and Contract Research Organizations (CROs) both large and small. For more information on purchasing this and other MCC Industry Practices Insight Reports, please email Customer Service
or visit our Industry Practices Insights Report Page

Read Linda Sullivan and Keith Dorricott’s article on Applied Clinical Trials Online

Performance Metrics: New eLearning Course Allows You to Go Beyond the Basics

Tuesday, April 25, 2017

MCC introduces a new eLearning course, Performance Metrics: Developing Effective Metrics Using a Structured Process that offers industry professionals a deeper understanding of how to select and use performance metrics to support a company’s strategic goals.

Using case study examples and easy-to-use worksheets, professionals will learn to use the MCC Metric Development Framework to establish metrics that align with each level of responsibility in your organization and support program goals and objectives. This easy to follow approach includes the following features:

  • Utilizing processes map to identify control points for metrics
  • Establishing critical success factors
  • Prioritizing key performance questions
  • Defining metrics that answer the key performance questions
  • Reporting metric results in formats that facilitate answering the key performance questions

The price of this course is $560* for members and $699 for non-members. There is also accreditation for 2 hours of CEUs accepted by ACRP and SoCRA.

* Discount code needed. For questions please contact Customer Service

MCC and Canadian Research Organization Alliance Group (N2) Announce Metric Education Collaboration

Tuesday, March 21, 2017


Boston, MA – Metrics Champion Consortium (MCC) and the Canadian-based Network of Networks group (N2) are working together to develop mutually attractive benefits for the two organizations and their members. Through the N2-MCC collaboration, MCC’s eLearning and Metric Master Certification Programs will be available to N2 members at a discounted rate. Participants will gain expertise in the design, implementation and effective use of clinical research performance metrics. eLearning courses include The Elements that Make Metrics Effective, Developing Effective Metrics Using a Structured Process and Effective Metric Visualizations to Gain Valuable Performance Insights. The Metric Master Certification Program allows participants to apply the knowledge they have gained from the eLearning courses to an independent project relevant to their organizations. Certification program participants receive one-on-one guidance from an MCC advisor and upon successfully completing the program receive an MCC Metric Master Certificate.

About N2

The Network of Networks (N2) is a not-for-profit incorporated organization and an alliance of Canadian research networks and organizations working to enhance national clinical research capability and capacity. N2 provides a common platform for sharing best practices, resources and research-related content to ensure efficient and high-quality research, integrity of clinical practices and accountability by bringing together trialists and clinical research professionals from across the country. The organization is truly representative of clinical research in Canada and acts as a national voice and advocate on behalf of a broad range of stakeholders that have an impact on the efficiency and quality of clinical trials conducted in Canada.

To learn more about N2, click here to visit their website.

About MCC

The Metrics Champion Consortium (MCC)—a trusted partner in the clinical trials industry—identifies what to measure, how to assess the critical components of what is changing and how the industry is responding to address the changes to make improvements. MCC continually brings you new insights into the leading trends within the industry.

To learn more about the MCC eLearning offerings, click here